17
Participants
Start Date
March 31, 2006
Primary Completion Date
May 31, 2008
Study Completion Date
October 31, 2009
Adenoviral-mediated Interferon-beta
BG00001 at doses 1.5 x 10e12 and 3 x 10e12 viral particles Days 1 and 8
SCH 721015
Comparison of different doses and frequency of investigational agent
Hospital of the University of Pennsylvania, Philadelphia
Collaborators (1)
National Cancer Institute (NCI)
NIH
Biogen
INDUSTRY
University of Pennsylvania
OTHER